Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases
CA 2500384 A1 · Owner: Areces, Liliana Beatriz · Inventors: Piccini, Daniele; Faretta, Mario; Pelicci, Pier Giuseppe
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method for determining whether a treatment of a disorder with an HDAC inhibitor is to be started/continued or not comprising determining the level of histone acetylation in the sample by use of an antibody capable of binding to acetylated histone and classifying the , disorder as to be treated with an HDAC inhibitor when the level of histone acetylation is significantly lower than that of a reference sample. The invention further relates to the diagnostic and prognostic use of specific antibodies and cell lines producing them.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 30, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 30, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 30, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.